
Next in pharma 2025: The future is now
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.
In today's fast-paced business environment, companies are realizing the importance of modernizing their back-office operations. The back office, which encompasses functions such as finance, supply chain, procurement, and manufacturing, has often been overlooked in favor of more client-facing initiatives. However, there is a growing recognition that an efficient back office can drive agility and productivity, enabling businesses to meet market demands and seize new opportunities. For companies in the medtech and biotech industries, back-office transformation is even more crucial. These organizations face unique challenges, such as navigating complex supply chain and manufacturing processes, managing inventory in unpredictable situations, and complying with global regulations.
In this Spotlight published by independent analyst firm IDC, you will learn:
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.
Life sciences companies are investing in technology that can connect people and processes through interoperable, integrated cloud-based ERP platforms.
The changing economy has slowed hypergrowth companies, many are now delaying going public as they work on their core business and financial processes.
Rattan Singh
Principal, PwC US